The seventh edition of SmiLe’s ten-week program for early companies and entrepreneurs with innovative ideas and products in healthtech, medtech and eHealth is now underway. The projects address key care-related areas such as pain, psychiatric disorders and postnatal problems. The goal is to make the projects investment-ready. The program culminates with a DemoDay on June 17.
Eight entrepreneurs have been accepted following a rigorous selection process and will spend ten weeks learning how to develop life science companies into investment-ready businesses. During the course, they will stress-test and fine-tune their business ideas through market verification and with other support from experts and SmiLe’s coaches, who collectively have over 300 years of experience in the life science industry.
Through SmiLe’s digital platform, where much of the program is provided in real time, participants receive industry-relevant knowledge and coaching, individually and in groups. The aim is to create a solid foundation and optimal conditions for successful projects that will benefit the health sector worldwide. The program includes market verification, health economics, pricing strategy, IP, regulatory strategy, business models and financing, as well as inspirational lectures presented by SmiLe incubator companies.
SmiLe’s Bootcamp (formerly known as Health2B) ranks among the top 15 healthtech accelerators in Europe and the top 5 in Sweden, and has been held six times previously with national and international entrepreneurs who have given the program 5-star reviews. For this round, one third of all applications came from international applicants.
“The high standard of the projects and the many international applicants confirm that our program content is both relevant and attractive. The entrepreneurs include both students and researchers, as well as many applicants from the business community. It confirms that more and more people see entrepreneurship as a career pathway and an opportunity to help solve various societal challenges,” says Ebba Fåhraeus, CEO of SmiLe Incubator.
After SmiLe Bootcamp, companies can become qualified for the SmiLe incubator program. Prior participants include Medow, which has developed an innovative wristband for intravenous tubes and which now has several international customers. Another examples is Acorai, which may be the first in the market with a noninvasive pressure monitoring device via smartphone for patients with heart failure.
Participants in the seventh edition of SmiLe Bootcamp have the following projects:
For more information, please contact: Ebba Fåhraeus, +46 (0)734 000 433, email@example.com
SmiLe Incubator is a life science business incubator based in Medicon Village in Lund, Sweden. SmiLe helps entrepreneurs to commercialize their ideas. There are currently 25 companies in SmiLe, which together with alumni companies, have attracted more than EUR 380 million in venture capital to date since 2014. SmiLe offers business coaching, a large network of contacts and a dynamic community, as well as well-equipped laboratories which is unique of its kind in Sweden. SmiLe is a non-profit organization and receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village. SmiLe´s sponsors are Agilent, Sparbanken Skåne, Awa, Høiberg, Prevas, Setterwalls, Zacco, Aqilion. SmiLe’s listed alumni companies have a market capitalization of EUR 1,28 billion (Q3 2020). www.smileincubator.life